An Approach for the Identification of Targets Specific to Bone Metastasis Using Cancer Genes Interactome and Gene Ontology Analysis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Vashisht, Shikha ^a   Bagler, Ganesh ^a  

^a CSIR INSTITUTE OF HIMALAYAN BIORESOURCE TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE METASTASIS; BREAST CANCER; CARCINOGENESIS; GENE TARGETING; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC TRANSFORMATION; HUMAN; PHENOTYPE; PROSTATE CANCER; TUMOR GENE;

BONE NEOPLASMS; COMPUTATIONAL BIOLOGY; GENES, NEOPLASM; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE ANNOTATION; NEOPLASM METASTASIS; PROTEIN INTERACTION MAPS;

EID: 84869113650     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049401     Document Type: Article

References (77)

1. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674 doi:10.1016/j.cell.2011.02.013.
2. Hanahan D, Weinberg RA, Francisco S, (2000) The Hallmarks of Cancer. Cell 100: 57-70 doi:10.1016/S0092-8674(00)81683-9.
3. Barabási A-L, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nature reviews Genetics 12: 56-68 doi:10.1038/nrg2918.
4. Ergün A, Lawrence CA, Kohanski MA, Brennan TA, Collins JJ, (2007) A network biology approach to prostate cancer. Molecular systems biology 3: 82 doi:10.1038/msb4100125.
5. Chuang H-Y, Lee E, Liu Y-T, Lee D, Ideker T, (2007) Network-based classification of breast cancer metastasis. Molecular systems biology 3: 140 doi:10.1038/msb4100180.
6. Chang W, Ma L, Lin L, Gu L, Liu X, et al. (2009) Identification of novel hub genes associated with liver metastasis of gastric cancer. International journal of cancer Journal international du cancer 125: 2844-2853 doi:10.1002/ijc.24699.
7. Talmadge JE, Fidler IJ, (2010) The biology of cancer metastasis: historical perspective. Cancer research 70: 5649-5669 doi:10.1158/0008-5472.CAN-10-1040.
8. Chaffer CL, Weinberg RA, (2011) A Perspective on Cancer Cell Metastasis. Science 331: 1559-1564 doi:10.1126/science.1203543.
9. Virk MS, Lieberman JR, (2007) Tumor metastasis to bone. Arthritis research & therapy 9: S5 doi:10.1186/ar2169.
10. Chu K, Cheng C-J, Ye X, Lee Y-C, Zurita AJ, et al. (2008) Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Molecular Cancer Research 6: 1259-1267 doi:10.1158/1541-7786.MCR-08-0077.
11. Kozlow W, Guise TA, (2005) Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. Journal of Mammary Gland Biology and Neoplasia 10: 169-180 doi:10.1007/s10911-005-5399-8.
12. Coleman RE (1997) Skeletal complications of malignancy. Cancer 801588-1594. doi:10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G.
13. Mundy GR, (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nature Reviews Cancer 2: 584-593 doi:10.1038/nrc867.
14. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, et al. (2006) Metastatic patterns in adenocarcinoma. Cancer 106: 1624-1633 doi:10.1002/cncr.21778.
15. Bu G, Lu W, Liu C-C, Selander K, Yoneda T, et al. (2008) Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases. International Journal of Cancer 123: 1034-1042 doi:10.1002/ijc.23625.
16. Cicek M, Oursler MJ, (2006) Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Reviews 25: 635-644 doi:10.1007/s10555-006-9035-x.
17. Guise TA, (2009) Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases. Genes & Development 23: 2117-2123 doi:10.1101/gad.1854909.
18. Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, et al. (2009) ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes & Development 23: 1882-1894 doi:10.1101/gad.1824809.
19. Smid M, Wang Y, Klijn JGM, Sieuwerts AM, Zhang Y, et al. (2006) Genes associated with breast cancer metastatic to bone. Journal of Clinical Oncology 24: 2261-2267 doi:10.1200/JCO.2005.03.8802.
20. Weigelt B, Peterse J, (2005) Breast cancer metastasis: markers and models. Nature reviews cancer 5: 591-602 doi:10.1038/nrc1670.
21. Zhang XH-F, Wang Q, Gerald W, Hudis CA, Norton L, et al. (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16: 67-78 doi:10.1016/j.ccr.2009.05.017.
22. Sloan EK, Anderson RL, (2002) Genes involved in breast cancer metastasis to bone. Cellular and Molecular Life Sciences 59: 1491-1502 doi:10.1007/s00018-002-8524-5.
23. Zhang X, Wang W, True LD, Vessella RL, Takayama TK, (2009) Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis. The Prostate 69: 727-736 doi:10.1002/pros.20920.
24. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, et al. (2002) Use of the Stromal Cell-derived Factor-1/CXCR4 Pathway in Prostate Cancer Metastasis to Bone. Cancer Research 62: 1832-1837.
25. Valta MP, Tuomela J, Bjartell A, Valve E, Väänänen HK, et al. (2008) FGF-8 is involved in bone metastasis of prostate cancer. International Journal of Cancer 123: 22-31 doi:10.1002/ijc.23422.
26. Secondini C, Wetterwald A, Schwaninger R, Thalmann GN, Cecchini MG, (2011) The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis. PloS One 6: e16078 doi:10.1371/journal.pone.0016078.
27. Koreckij T, Nguyen H, Brown LG, Yu EY, Vessella RL, et al. (2009) Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. British Journal of Cancer 101: 263-268 doi:10.1038/sj.bjc.6605178.
28. Bailey CL, Kelly P, Casey PJ, (2009) Activation of Rap1 promotes prostate cancer metastasis. Cancer Research 69: 4962-4968 doi:10.1158/0008-5472.CAN-08-4269.
29. Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, et al. (2006) Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107: 289-298 doi:10.1002/cncr.21978.
30. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, et al. (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440: 692-696 doi:10.1038/nature04524.
31. Jeong H, Mason SP, Barabási AL, Oltvai ZN, (2001) Lethality and centrality in protein networks. Nature 411: 41-42 doi:10.1038/35075138.
32. Batada NN, Hurst LD, Tyers M, (2006) Evolutionary and physiological importance of hub proteins. PLoS Computational Biology 2: e88 doi:10.1371/journal.pcbi.0020088.
33. Freeman L, (1977) A Set of Measures of Centrality Based on Betweenness. Sociometry 40: 35-41.
34. Brandes U, (2001) A faster algorithm for betweenness centrality. Journal of Mathematical Sociology 25: 163-177 doi:10.1080/0022250X.2001.9990249.
35. Joy MP, Brock A, Ingber DE, Huang S, (2005) High-betweenness proteins in the yeast protein interaction network. Journal of Biomedicine & Biotechnology 2005: 96-103 doi:10.1155/JBB.2005.96.
36. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M, (2007) The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Computational Biology 3: e59 doi:10.1371/journal.pcbi.0030059.
37. Jonsson PF, Bates PA, (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22: 2291-2297 doi:10.1093/bioinformatics/btl390.
38. Gene T, Consortium O, (2001) Creating the Gene Ontology Resource□: Design and Implementation. Genome Research 11: 1425-1433 doi:10.1101/gr.180801.examining.
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide. PNAS 102: 15545-15550 doi:10.1073/pnas.0506580102.
40. Rhee SY, Wood V, Dolinski K, Draghici S, (2008) Use and misuse of the gene ontology annotations. Nature reviews Genetics 9: 509-515 doi:10.1038/nrg2363.
41. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z, (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48 doi:10.1186/1471-2105-10-48.
42. Huang DW, Sherman BT, Lempicki R a, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37: 1-13 doi:10.1093/nar/gkn923.
43. Emmert-Streib F, (2007) The chronic fatigue syndrome: a comparative pathway analysis. Journal of computational biology 14: 961-972 doi:10.1089/cmb.2007.0041.
44. Jia P, Kao C-F, Kuo P-H, Zhao Z, (2011) A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Systems Biology 5: S12 doi:10.1186/1752-0509-5-S3-S12.
45. Cerami E, Demir E, Schultz N, Taylor BS, Sander C, (2010) Automated network analysis identifies core pathways in glioblastoma. PloS one 5: e8918 doi:10.1371/journal.pone.0008918.
46. Lascorz J, Hemminki K, Försti A, (2011) Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development. Journal of carcinogenesis 10: 7 doi:10.4103/1477-3163.78268.
47. Ortutay C, Vihinen M, (2009) Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies. Nucleic Acids Research 37: 622-628 doi:10.1093/nar/gkn982.
48. Higgins ME, Claremont M, Major JE, Sander C, Lash AE, (2007) CancerGenes: a gene selection resource for cancer genome projects. Nucleic Acids Research 35: D721-6 doi:10.1093/nar/gkl811.
49. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, et al. (2003) Development of Human Protein Reference Database as an Initial Platform for Approaching Systems Biology in Humans. Genome Research 13: 2363-2371 doi:10.1101/gr.1680803.17.
50. Dorogovtsev S, (2004) The shortest path to complex networks. Arxiv preprint cond-mat/0404593: 1-25.
51. Albert R, Barabasi A-L (2002) Statistical mechanics of complex networks. Reviews of Modern Physics 74. doi:10.1103/RevModPhys.74.47.
52. Clauset A, Shalizi CR, Newman MEJ, (2009) Power-Law Distributions in Empirical Data. SIAM Review 51: 661-703 doi:10.1137/070710111.
53. Barabási A-L, Oltvai ZN, (2004) Network biology: understanding the cell's functional organization. Nature reviews Genetics 5: 101-113 doi:10.1038/nrg1272.
54. Maslov S, Sneppen K, (2002) Specificity and stability in topology of protein networks. Science 296: 910-913 doi:10.1126/science.1065103.
55. Watts DJ, Strogatz SH, (1998) Collective dynamics of 'small-world' networks. Nature 393: 440-442 doi:10.1038/30918.
56. Newman MEJ, Watts DJ, Strogatz SH, (2002) Random graph models of social networks. Proceedings of the National Academy of Sciences of the United States of America 99 (Suppl 1): 2566-2572 doi:10.1073/pnas.012582999.
57. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122: 957-968 doi:10.1016/j.cell.2005.08.029.
58. Wyllie AH, Kerr JFR, Currie AR, (1980) Cell death: the significance of apoptosis. International Review of Cytology 68: 251-306 doi:10.1016/S0074-7696(08)62312-8.
59. Harris CC, (1996) P53 Tumor Suppressor Gene: From the Basic Research Laboratory To the Clinic-an Abridged Historical Perspective. Carcinogenesis 17: 1187-1198 doi:10.1093/carcin/17.6.1187.
60. Levine AJ, (1997) P53, the Cellular Gatekeeper for Growth and Division. Cell 88: 323-331 doi:10.1016/S0092-8674(00)81871-1.
61. Dai JL, Bansal RK, Kern SE, (1999) G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. Proceedings of the National Academy of Sciences of the United States of America 96: 1427-1432 doi:10.1073/pnas.96.4.1427.
62. KEGG-Pathways in cancer: hsa05200 (n.d.). Available:http://www.genome.jp/dbget-bin/www_bget?pathwayhsa05200.
63. Smith CL, Goldsmith C-AW, Eppig JT, (2005) The Mammalian Phenotype Ontology as a tool for annotating, analyzing and comparing phenotypic information. Genome Biology 6: R7 doi:10.1186/gb-2004-6-1-r7.
64. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proceedings of the National Academy of Sciences 104: 8685-8690 doi:10.1073/pnas.0701361104.
65. Blake JA, Bult CJ, Kadin JA, Richardson JE, Eppig JT, (2011) The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Research 39: D842-8 doi:10.1093/nar/gkq1008.
66. Rangaswami H, Bulbule A, Kundu GC, (2006) Osteopontin: role in cell signaling and cancer progression. Trends in cell biology 16: 79-87 doi:10.1016/j.tcb.2005.12.005.
67. Rittling SR, Chambers AF, (2004) Role of osteopontin in tumour progression. British journal of cancer 90: 1877-1881 doi:10.1038/sj.bjc.6601839.
68. Wang H-S, Hung Y, Su C-H, Peng S-T, Guo Y-J, et al. (2005) CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). Experimental cell research 304: 116-126 doi:10.1016/j.yexcr.2004.10.015.
69. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer cell 3: 537-549.
70. Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, et al. (2004) Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. The Journal of biological chemistry 279: 27560-27566 doi:10.1074/jbc.M404222200.
71. Matsumoto K, Takayama N, Ohnishi J, Ohnishi E, Shirayoshi Y, et al. (2001) Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes to cells 6: 1101-1111.
72. Eppert K, Wunder JS, Aneliunas V, Kandel R, Andrulis IL, (2005) von Willebrand factor expression in osteosarcoma metastasis. Modern pathology 18: 388-397 doi:10.1038/modpathol.3800265.
73. Hahn WC, Weinberg RA, (2002) Modelling the molecular circuitry of cancer. Nature reviews Cancer 2: 331-341 doi:10.1038/nrc795.
74. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nature medicine 10: 789-799 doi:10.1038/nm1087.
75. Mathivanan S, Periaswamy B, Gandhi TKB, Kandasamy K, Suresh S, et al. (2006) An evaluation of human protein-protein interaction data in the public domain. BMC bioinformatics 7: S19 doi:10.1186/1471-2105-7-S5-S19.
76. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 13: 2498-2504 doi:10.1101/gr.1239303.
77. Yildirim MA, Goh K-I, Cusick ME, Barabási A-L, Vidal M, (2007) Drug-target network. Nature biotechnology 25: 1119-1126 doi:10.1038/nbt1338.